This image is not available for purchase in your country.

Ebola vaccine trial

Ebola vaccine trial

C021/7849

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

NATIONAL INSTITUTES OF HEALTH / SCIENCE PHOTO LIBRARY NATIONAL INSTITUTES OF HEALTH / SCIENCE PHOTO LIBRARY

Caption

Ebola vaccine trial. Man receiving a dose of the investigational NIAID/GSK ebola vaccine. This trial will determine if the vaccine is safe in humans and if it induces an adequate immune response. The vaccine uses a chimpanzee cold virus (chimp adenovirus type 3) to carry segments of genetic material from two ebola viruses. The viruses cause ebola virus disease (EVD), a severe and often fatal disease with symptoms including fever, fatigue, muscle aches, vomiting, diarrhoea and haemorrhaging (internal bleeding). It is spread through direct contact with infected bodily fluids. There is no cure for the disease, but three quarters of patients can recover if provided with sufficient medical support. Photographed at the NIH Clinical Center, Bethesda, Maryland, USA, on 4th September 2014.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}